Changes in the primary outcome in Ebola vaccine trial--Authors' reply.
Assistant Director General, Health Systems and Innovation, 1211 Geneva 27, Switzerland. Electronic address: kienym@who.int.
Marie Paule
MP
Kieny
Department of Biostatistics, University of Florida, Gainesville, FL, USA.
Ira M
IM
Longini
Assistant Director General, Health Systems and Innovation, 1211 Geneva 27, Switzerland.
Ana Maria
AM
Henao-Restrepo
Faculty of Epidemiology & Population Health, London School of Hygiene & Tropical Medicine, London, UK.
Conall H
CH
Watson
Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town, South Africa.
Matthias
M
Egger
Faculty of Epidemiology & Population Health, London School of Hygiene & Tropical Medicine, London, UK.
W John
WJ
Edmunds
D046129:Ebola Vaccines; D005260:Female; D019142:Hemorrhagic Fever, Ebola / Q000517:prevention & control*; D006801:Humans; D008297:Male
D046129:Ebola Vaccines